k .
Sudden unexpected d e a t h among IDDM i s a major m e d i c a l problem Our e x p e r i e n c e a t H u t z e l H o s p i t a l shows a v e r y h i g h i n c i d e n c e of SIDS among t h e IDDM (17l1000). A r e t r o s p e c t i v e s t u d y of IDDM was performed t o determine i f any n e o n a t a l f a c t o r s e x i s t w h i c h may
p r e d i s p o s e t o sudden unexpected i n f a n t death.
RESULTS: From 9/74 t o 9/77 a t o t a l o f 637 f u l l t e r m IDDM weighing a t l e a s t 2268 g were d e l i v e r e d . U s i n g t h e c r i t e r i a p r e v i o u s l . r e p o r t e d , t h e s e v e r i t y o f n e o n a t a l d r u g w i t h d r a w a l was assessed: 89% (5641637) had minor t o m i l d (MM) and 12% (731637) moderate t m severe (MS) w i t h d r a w a l . Two p e r c e n t (141637) were l a t e r r e p o r t e d t o have d i e d o f SIDS. A s i g n i f i c a n t l y h i g h e r number o f i n f a n t s w i t h MS (6173) d i e d o f SIDS compared t o t h o s e w i t h MM w i t h d r a w a l (8/564), X2=9.060, ~~0 . 0 1 .
Those who d i e d had no s i g n i f i c a n t med i c a l problems d u r i n g t h e n e o n a t a l p e r i o d . A l l d i e d between 4-16 weeks of age: 57% i n Winter, 21% i n Summer and 21% i n t h e F a l l .
CONCLUSION:
1) The frequency o f SIDS i s h i g h e r among IDDM comp a r e d t o t h e g e n e r a l p o p u l a t i o n . 2) A s i g n i f i c a n t l y h i g h e r i n c idence o f i n f a n t s w i t h MS w i t h d r a w a l d i e d from SIDS compared t o t h o s e who had l e s s e r degrees o f w i t h d r a w a l . 3) Since t h e r e i s a c o r r e l a t i o n between m a t e r n a l methadone dose and s e v e r i t y of neon a t a l w i t h d r a w a l ( J P e d i a t , A p r i 1 / 7 6 ) , t h e use of l o w methadone dosage d u r i n g pregnancy i s s t r o n g l y recommended.
tem Canc. Ctr., Dept. P e d i a t r . , The Univ. o f Houston, Dept. Pharm., Houston, Texas.
Amikacin i s an aminoglycoside a n t i b i o t i c t h a t i s e f f e c t i v e a g a i n s t gram n e g a t i v e b a c i l l i which a r e r e s i s t a n t t o o t h e r aminoglycoside a n t i b i o t i c s . S i x and 8 hour serum c o n c e n t r a t i o n s were 1.27f1.26 and 0.64i-0.92 u g l m l , r e s p e c t i v e l y .
The tL, was +43.8 minutes and t h e t o t a l c l e a r a n c e was 133+43 m l l m i n l 1 . 
A 9% i n a c t i v a t i o n o f a m i k a c i n o c c u r r e d when i n c u b a t e d i n normal
donor s e r a a t 3 7 O~ f o r 72 hours w i t h v a r y i n g c o n c e n t r a t i o n s o f t i c a r c i l l i n .
Due t o t h e r a p i d r e n a l c l e a r a n c e and s h o r t h a l f l i f e o f amikacin i n these c h i l d r e n , t h e c u r r e n t l y recommended dose o f amikacin s h o u l d be i n c r e a s e d and t h e frequency of a d m i n i s t r a t i o n shortened.
PLACENTAL TRANSFER O F MORPHINE I N T H E EWE
M a r t i n S.Cohen,Abraham M.Rudolph and Kenneth L.Melmon U n i v e r s i t y of C a l i f o r n i a San F r a n c i s c o , Departments of nd Medicine, San F r a n c i s c o . Maternal and fetal plasma clearance of morphine(M) as well as maternal to fetal and fetal to maternal clearance of M were studied i n 4 chroni c a l l y catheterized pregnant ewes and t h e i r fetuses. Morphine sulfate was infused into the ewes at a r a t e of 0.329 f 0.06 mg/min f o r 4 h o u r s . A r t e r i a l plasma M concentrations were measured b y radioimmunoassay at specific i n t e r v a l s i n the ewes and fetuses d u r i n g and a f t e r the infusion. Twenty-four h o u r s l a t e r , M was infused into the fetuses at a r a t e of 0.054f0.013 mg/min f o r 4 h o u r s and respective M concentrations measured. D u r i n g the maternal infusion, the steady state plasma concentration of M achieved by the ewes was 97.8 t 17.6 ng/ml and by the fetuses 14.7f 8 . 4 ng/rnl. D u r i n g the fetal infusion, the steady state plasma concentration of M achieved by the fetuses was 141.2t 63.4 ng/ml andby the ewes 3 . 5 t 1 .7 ng/ml. Plasma clearance of M i n the ewes was 3369 t 3 9 7 ml/min and i n the fetuses was 4 2 5 t 150 ml/min. The maternal to fetal clearance of M was 65.1 f 4 0 . 4 ml/rnin.The fetal to maternal clearanceof M was 84.4k 33.2 m l i m i n . These r e s u l t s indicate that only 20.01 5.0 70 of the total fetal clearance can be accounted f o r by fetal to maternal clearance. T h i s suggests that maternal clearance of morphine i s not the major route of elimination f o r the fetus. I t cannot be assumed,however, that the remaining clearance i s exclusively fetal metabolism since renal excretion of unchanged d r u g and placental metabolism were l o t deter-S P O N S E S T O M O R P H I N E I N THE P R E G N A N T E W E ? t i n S.Col-ien,Abraham M.Rudolph and Kenneth L.Melmon n l v e r s l t y of C a l i f o r n i a San Francisco,Departments of p e d i a t r i c s a n d Medicine,San F r a n c i s c o . I t i s not known whether the fetus can develop opiate dependence(0D) as a primary,drug-related effect of maternal to fetal t r a n s f e r o f morphine s u l f a t e ( M S ) o r whether fetal responses a r e r e l a t e d t o a l t e r e d maternal physiology.Four non-pregnant and 4 pregnant ewes werestudied. A continuous intravenous(1V)infusion of MS was g i v e n t o t h e ewes(lOmg/ kg/24 hours). The response was measured to I Vadministration of naloxone(N), 0.04mg/kg to the ewes and 0.02mq/kg-estimatrd weight to the fetuses. As e a r l y as 2 4 h o u r s a f t e r beginning theMS infusion,N increased a r t e r i a l blood p r e s s u r e ( A B P ) i n the non-pregnant ewes (mean t S E ) : s y s t o l i c 1 2 0 . 2 t 2 . 2 t o r r to 1 3 7 . 6 k 2 . 4 ( p < . O O I ) ; d i a s t o l i~ 8 2 . J t 1.2 1095.9 t 2.7 (p< .001);and i n pregnant ewes: systolic 114.2f 2.6 to 1 4 0 . 7 1 3 . 0 (p< .001). A l l animals demonstrated "withdrawal" responses.There was no significant change i n heart r a t e . Maternal N increasedfetal ABP. sys t o l i c 63.9f 2.1 to 7 5 . 0 k 4 . 2 (p<.001), diastolic 36.81 2.0 to 4 1 . 8 f 2 . 7 (p< .001). I n contrast to the mothers,there was a f a I I i n fetal heart rate: 174f 6 to 1 5 0 t 5 (p<.001) and p 0 2 24.4f 0.81 to 22.2? 1.04 (p5.05)and
DECREASE IN a-ADRENERGIC BINDING SITES IN NEWBORN

PLATELETS: CAUSE OF ABNORMAL RESPONSE TO EPINEPHRINE,
Corby, D.G., Barber, J.A., and OIBarr, T.P. C l i n i c a l I n v e s t i g a t i o n S e r v i c e , F i t z s i m n s Army Medical Center, Denver, Cc P l a t e l e t s o f newborn i n f a n t
s show d i m i n i s h e d a g g r e g a t i o n t o ep. ~n e p h r i n e . Because e p i n e p h r i n e -i n d u c e d a g g r e g a t i o n i s an a-adree r g i c r e c e p t o r -m e d i a t e d response, we considered t h e p o s s i b i l i t y t h a t p l a t e l e t s o f newborn i n f a n t s possess fewer e p i n e p h r i n e b i n d i n g s i t e s than do those o f j d u l t s . Using t h e s p e c i f i c and p o t e n t -a d r e n e r g i c a n t a g o n i s t , [ HI d i h y d r o e r g o c r y p t ine ( D H E ) , we corn, f pared t h e s p e c i f i c DHE b i n d i n g t o a-a d r e n e r g i c b i n d i n g s i t e s i n p l a t e l e t s from p a i r e d maternal and c o r d b l o o d samples. P l a t e l e t s
e r e washed t w i c e w i t h b u f f e r ( T r i s -H C I , 0.05 M, pH 7.35; NaCI, 0.15 H EDTA, 0.02 M) and incubated w i t h e i t h e r 5 nM [ HI DHE o r 5 nM [ 3~] DHE + 1 m M e p i n e p h r i n e . A f t e r 18 min, t h e r e a c t i o n was stopped by adding excess b u f f e r and t h e p l a t e l e t s were recovered by f i l t e r i n g on Whatman GFC g l a s s f i b e r f i l t e r s . Mate n a l p l a t e - e t s a r e t h e same s l z e , i t appears t h a t newborn p l a t e l e t s have fewer b i n d i n g s i t e s f o r e p i n e p h r i n e than maternal p l a t e l e t s . The above d a t a i s cons i s t e n t w i t h t h e h y p o t h e s i s t h a t p l a t e l e t s from newborns have a) d i m i n i s h e d a g g r e g a t i o n response t o e p i n e p h r i n e secondary t o decreased numbers o f r e c e p t o r s and b ) n -a d r e n e r g i c r e c e p t o r s t h a a r e e i t h e r down r e g u l a t e d o r not f u l l y developed.
INTRAVENOUS GENTAMICIN PHARMACOKINETICS I N THE SMALL
(Spon. by John 0. Madden) Gentamicin (G) i s an aminoglycoside f r e q u e n t l y used i n t h e t r e a t m e n t o f neonatal s e p s i s and m e n i n g i t i s . T h i s s t u d y r e p o r t s f o r t h e f i r s t t i m e t h e s e q u e n t i a l pharmacokinetics o f a c o n s t a n t r a t e one hour i n t r a v e n o u s G i n f u s i o n i n 60 small p r e t e r m i n f a n t s d u r i n g t h e f i r s t week o f use. Using a m i c r o b i o l o g i c technique, t h e serum G c o n c e n t r a t i o n ( l e v e l ) was measured b e f o r e t h e 2.5 rnglkg G i n f u s i o n and 1, 2, 4, 8, and 12 hours a f t e r t h e i n f u s i o n was s t a r t e d . Mean b i r t h w e i g h t and g e s t a t i o n a l age were 1365 grams (700-2000) and 30.5 weeks (24-36).
P o t e n t i a l l y t o x i c t r o u g h and peak l e v e l s were observed i n some cases a l o n g w i t h a markedly prolonged h a l f l i f e (t',). The peak, 2 hour ( h r ) , and 12 h r ( t r o u g h ) l e v e l s were 8.25 ( 1 . 7 -13.0), 5.76 (.25-13.0), and 2.03 (.25-10.8) y g / m l r e s p e c t i v e l y . Drug accumulation was documented. I n c r e a s i n g peak l e v e l s were a s s o c i a t e d w i t h i n c r e a s e d t r o u g h l e v e l s and decreased volume of d i s t r i b u t i o n ( Y o ) Trough l e v e l s i n c r e a s e d as dose and day of t r e a t m e n t i n c r e a s e d and as VD decreased. Drug d i s p o s i t i o n was very r a p i d d u r i n g t h e f i r s t 4 h r s and s l o w e r d u r i n g t h e l a s t 8 h r s s u g g e s t i n g a two compartment process. T1,was 12.36 h r s and VO ,802 L / k g (6.82 h r s and 0.629 L / k g r e s p e c t i v e l y u s i n g a one compartment model). Biweekly m o n i t o r i n g o f t r o u g h and peak l e v e l i s necessary t o a v o i d peak l e v e l s >12 u g l m l and t r o u g h l e v e l s > 2 iug/rnl w h i l e m a i n t a i n i n g t h e r a p e u t i c l e v e l s o f 4-5 ,ug/ml.
